Neviah Genomics Ltd
Questions?
Please contact Sales at: (212) 520-2765 or email [email protected]
Latest From Neviah Genomics Ltd
Deals Shaping The Medical Industry, September 2012
The Dealmaking column is a survey of recent transactions, including strategic alliances, mergers & acquisitions, and financings, in the life sciences industries. Deals are listed by the following industry sectors: in vitro diagnostics, medical devices, pharmaceuticals, and research/analytical instrumentation and reagents. All transactions are excerpted from Elsevier's Strategic Transactions database, providing comprehensive transaction coverage from 1991 to the present.
Prexton Therapeutics’ Parkinson’s Assets First to Emerge from Merck KGAA Restructuring
Prexton Therapeutics will be headquartered at the Eclosion incubator facility in Geneva and will advance mGluR compounds for Parkinson’s from the Merck Serono portfolio.
Out Of The Blocks, July-August 2012
Brief profiles of these recently formed companies: BriteSeed, Cool-Bio, Euclises Pharmaceuticals, Global Blood Therapeutics, Magenta Medical and Neviah Genomics.
Company Information
- Industry
- Contract Research, Toxicology Testing-CRO
-
Biotechnology
- Drug Discovery Tools
You must sign in to use this functionality
Authentication.SignIn.HeadSignInHeader
Email Company
All set! This article has been sent to my@email.address.
All fields are required. For multiple recipients, separate email addresses with a semicolon.
DCD.EmailPopout.Notice